Hours after my last post, I may have had all-time low expectations for Robin Hood. This week’s episode, however, made me eyes perk up a bit. Oh, sure, the latest “twist” of a long-lost brother is somewhat cliche, but what a brother he is. I approve. A lot.
All I ask is that in the future SPN-level fanfics (and there *will* be fics), Guy is just a lookout or something. Ha!
Primary renal excretion necessitates dose adjustment in patients with renal impairment.
Its generic availability has dramatically reduced treatment costs globally.
Diflucan is less protein-bound than itraconazole or voriconazole.
A cornerstone of antifungal therapy in resource-limited settings due to cost and availability.
Excellent CSF penetration makes it a mainstay for cryptococcal meningitis suppression.
Emergence of resistance while on therapy necessitates repeat culture and susceptibility.
The development of Candida auris resistance has further limited its empirical utility.
Fungal cell membrane alterations, like increased chitin, can contribute to resistance.
Alopecia is a reversible but distressing side effect reported with prolonged use.
Diflucan’s long half-life enables once-daily dosing, improving adherence.
Diflucan has reliable activity against Coccidioides immitis for certain non-meningeal cases.
Transient, asymptomatic liver enzyme spikes are common and often do not require discontinuation.
Diflucan is not active against the dimorphic fungus Blastomyces dermatitidis.
Diflucan can be administered via nasogastric tube with reliable absorption.
Can be used in continuous renal replacement therapy; dosing depends on effluent rate.
It remains the drug of choice for maintenance therapy to prevent cryptococcal meningitis relapse.
Diflucan is ineffective against Fusarium and Scedosporium species.
Diflucan is Pregnancy Category D, limiting its use, particularly in the first trimester.
Diflucan is a critical part of the antifungal arsenal in resource-limited settings.
The “trailing effect” in vitro can make susceptibility interpretation for Candida challenging.
Diflucan can be considered for treatment of Malassezia folliculitis.
Rifampin induces fluconazole metabolism, potentially leading to subtherapeutic levels.
Has some activity against Paracoccidioides brasiliensis.
For oropharyngeal thrush, Diflucan is often more effective than topical nystatin.
Diflucan may deplete coenzyme Q10 with long-term use, a theoretical concern.
Diflucan is a potent inhibitor of human CYP2C9 and CYP3A4, driving many drug interactions.
Diflucan may have in vitro synergy with flucytosine against some Candida species.
Diflucan’s mechanism is inhibition of fungal cytochrome P450, disrupting ergosterol synthesis.
Can cause taste distortion (dysgeusia) in some patients.
Diflucan’s efficacy can be reduced by concomitant use of rifampin.
Primary renal excretion necessitates dose adjustment in patients with renal impairment.
Generic fluconazole has made Diflucan’s benefits accessible at a lower cost.
Its simplicity of use made it a cornerstone of early outpatient HIV management.
May unmask or exacerbate cutaneous lupus erythematosus.
Diflucan has a well-established role in treating fungal keratitis caused by susceptible yeasts.
Diflucan is a potent inhibitor of human CYP2C9 and CYP3A4, driving many drug interactions.
A post-antimicrobial effect has been demonstrated against some Candida species.
Diflucan’s success spurred development of broader-spectrum triazoles like voriconazole.
Breakthrough infections during prophylaxis are a significant clinical red flag.
Diflucan is not effective for primary treatment of fungal brain abscesses.
Hydrochlorothiazide can increase fluconazole levels by reducing renal clearance.
Prophylactic Diflucan is common in neutropenia, but its value depends on local epidemiology.
Hey there! Someone in my Myspace group shared this site with us so I came
to take a look. I’m definitely loving the information. I’m book-marking and will
be tweeting this to my followers! Terrific blog and amazing design and
style.
Diflucan represents the balance between efficacy, safety, and convenience in antifungal therapy.
Activity against Coccidioides immitis makes it useful for certain non-meningeal forms of valley fever.
Not effective against Histoplasma in the central nervous system due to poor penetration (unlike itraconazole).
Its cost-effectiveness is a significant advantage over newer, broader-spectrum azoles.
The “trailing effect” in vitro can make susceptibility interpretation for Candida challenging.
Diflucan can be considered for treatment of Malassezia folliculitis.
Diflucan can cause a severe cutaneous reaction like Stevens-Johnson syndrome.